BioSpace News Archive

Camargo Pharmaceutical Services, LLC, a global drug development and commercial partner, announced today the appointment of Robb Lawrence as Vice President of Commercial Strategy. In this senior leadership role, Lawrence will lead the design and development of strategic solutions that optimize patient access and outcomes by navigating the

The Montreal Heart Institute (MHI) released earlier today two more research publications confirming the benefits of low dose (0,5mg daily) colchicine in preventing the risks of ischemic cardiovascular events in patients having undergone myocardial infarction (MI). These were sub-analyses of the landmark COLCOT I trial carried out last year

As previously announced, Biotage AB (publ) (Biotage) has during August 2020 issued 243,313 new class C shares in accordance with the incentive program LTIP 2020 which was adopted by the Annual General Meeting held on June 4, 2020 . Prior to the issue, the total number of outstanding shares and votes in Biotage amounted to 65,

In lieu of an in-person update to the media, Dr. Theresa Tam, Canada’s Chief Public Health Officer, issued the following statement